Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection

Journal of Thoracic and Cardiovascular Surgery

Volumn 117, Issue 4, 1999, Pages 714-718

  Longoria, J ^a   Roberts, R F ^a   Marboe, C C ^a   Stouch, B C ^a   Starnes, V A ^a   Barr, M L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032931245     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70291-6     Document Type: Article

References (15)

1. SM Stepkowski H Chen P Daloze BD Kahan Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat Transplantation 51 1991 22 26
2. RE Morris In vivo immunopharmacology of the macrolides FK506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use Transplant Proc 23 1991 2722 2724
3. FJ Dumont MJ Staruch SL Koprak Distinct mechanism of suppression of murine T cell activation by the related macrolides FK506 and rapamycin J Immunol 144 1990 251 252
4. SM Stepkowski H Chen P Daloze BD Kahan Prolongation by rapamycin of heart, kidney, pancreas and small bowel allograft survival in rats Transplant Proc 23 1991 507 508
5. KW Marck CRH Wildevuur Lung transplantation in the rat: technique and survival Ann Thorac Surg 34 1982 74 80
6. J Prop MG Ehrie JD Crapo NCP Nieuwenhuis CRH Wildevuur Reimplantation response in isografted rat lungs: analysis of causal factors J Thorac Cardiovasc Surg 87 1984 702 711
7. GJ Berry EM Brunt D Chamberlain RH Hruban RK Sibley S Stewart A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group J Heart Lung Transplant 9 1990 593 601
8. RJ Keenan H Konishi A Kawai IL Paradis DR Nunley AT Iacono Clinical trial of tacrolimus versus cyclosporine in lung transplantation Ann Thorac Surg 60 1995 580 585
9. K Bando IL Paradis S Similo K Konishi K Konatsu TG Zullo Obliterative bronchiolits after lung and heart-lung transplantation: an analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4 14
10. CA Keller PT Cagle RW Brown G Noon A Frost Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation Chest 107 1995 973 980
11. T Ochiai Y Gunji M Nagata A Komori T Asano K Isono Effects of rapamycin in experimental organ allografting Transplantation 1993 5615 5619
12. H Chen J Wu H Luo P Daloze Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat Tranplant Proc 24 1992 892 893
13. BD Kahan S Gibbons N Tejpal SM Strepkowski T-C Chou Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro Transplantation 51 1991 232 239
14. R Knight M Ferraresso F Serino S Katz R Lewis BD Kahan Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model Transplantation 55 1993 947 949
15. SM Strepkowski BD Kahan Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival Transplant Proc 23 1991 3262 3264